Hepatitis E News and Research

RSS

Hepatitis E is a viral hepatitis (liver inflammation) caused by infection with a virus called hepatitis E virus (HEV).

Racial gap in childhood vaccination rate closes

The overall vaccination rate among black children ages 19 months to 35 months last year for the first time equaled rates among white, Asian and Hispanic children in the same age group, according to a CDC report released recently, the AP/Seattle Post-Intelligencer reports.

18 Sep 2006

Treatments used for SARS no benefit to victims

Researchers have found, following a systematic review of all studies done on the 2003 SARS epidemic, that none of the treatments used to treat patients appear to have worked.

13 Sep 2006

Eating mandarins reduces the risk of liver disease, hardened arteries and insulin resistance

Researchers in Japan say they believe that eating mandarins may cut the risk of developing liver cancer and other diseases.

12 Sep 2006

Colchicine delays development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis

Colchicine, an anti-inflammatory drug most often used to treat gout, prevented liver cancer in patients with hepatitis virus-related end-stage liver disease, according to a new study.

11 Sep 2006

Sacramento City Council approves sale of nonprescription needles

The Sacramento, Calif., City Council on Tuesday voted 6-2 to approve a measure that will allow the nonprescription sale of syringes to adults, the Sacramento Bee reports (Stern, Sacramento Bee, 9/6).

7 Sep 2006

Fewer deaths from cancer in the U.S.

According to a new report fewer Americans are dying of cancer even though the rates of new cancers remains the same.

7 Sep 2006

Supervised drug-injection facility in Vancouver, Canada, to remain open until December 2007

A supervised drug-injection facility in Vancouver, Canada, will remain open until December 2007 after it received a reprieve on Friday from Health Minister Tony Clement, Toronto's Globe and Mail reports (Fong, Globe and Mail, 9/2).

6 Sep 2006

Racial differences in hepatitis C viral responses

African American patients with hepatitis C (HCV) infections experience a lower response rate to the peginterferon alfa-2a and ribavirin combination treatment than Caucasian Americans, according to a study published in the August issue of Gastroenterology.

16 Aug 2006

Turning the immune system against cancer

Medicine can now prevent a host of diseases with a mere shot of vaccine. Polio and smallpox are almost non-existent, and mumps and chicken pox are rarely seen nowadays.

4 Aug 2006

Scientists identify genetic element that the dengue virus uses to replicate

The first step in the transmission of mosquito-borne viruses is no mystery: it's the pesky insect's bite that allows the virus to enter its victim's bloodstream.

2 Aug 2006

Deadly duo of crime and drug abuse can be cut by effective treatments

According to a landmark scientific report released by the National Institute on Drug Abuse (NIDA), money would be saved and crime would be reduced if communities put into place effective treatments for drug abuse and addiction.

26 Jul 2006

Healthcare providers react more positively to men than women who reveal they're gay

Men and people over 40 are much more likely to report positive experiences when they tell healthcare providers they are not heterosexual, according research in the latest UK-based Journal of Advanced Nursing.

24 Jul 2006

New laser test screens for Hepatitis B

The U.S. Food and Drug Administration has given the go-ahead for a device, called Cell-Dyn Ruby, which uses laser optics and provides diagrams showing changes in white and red blood cells and platelets.

20 Jul 2006

Canada ready to vaccinate against human papillomavirus

Canadian women will soon be able to access the first vaccine to protect against the sexually transmitted virus that causes cervical cancer.

19 Jul 2006

FDA approves fully automated screening tests for hepatitis B surface antigen

The Food and Drug Administration (FDA) has announced the approval of the first fully automated product that combines both screening and confirmatory tests for hepatitis B surface antigen (HBsAg).

18 Jul 2006

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

FDA approves Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs.

12 Jul 2006

Fombonne's autism research is dangerously inaccurate

Fombonne, a thimerosal litigation expert witness on behalf of various pharmaceutical companies, will reportedly state that it is "very clear" there is no relationship between mercury-based thimerosal and the onset of autism.

11 Jul 2006

Statins stop the replication of the hepatitis C virus

A new study shows that statins, which are typically used as anti-cholesterol medications, can inhibit the replication of the hepatitis C virus (HCV).

9 Jul 2006

Scientists find a cytokine against auto-immune hepatitis

There are about 400 million patients of hepatitis in the world. Some of them are suffering from autoimmune hepatitis, a disease in which the body's immune system attacks liver cells.

5 Jul 2006